{"id":"NCT00258895","sponsor":"Sanofi Pasteur, a Sanofi Company","briefTitle":"Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®","officialTitle":"Safety and Immunogenicity of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With DAPTACEL® or Pentacel®","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-03","primaryCompletion":"2006-12","completion":"2007-04","firstPosted":"2005-11-28","resultsPosted":"2009-09-28","lastUpdate":"2016-04-14"},"enrollment":649,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Diphtheria","Tetanus","Pertussis"],"interventions":[{"type":"BIOLOGICAL","name":"DAPTACEL®: DTaP","otherNames":["DAPTACEL®"]},{"type":"BIOLOGICAL","name":"DAPTACEL®: DTaP","otherNames":["DAPTACEL®"]}],"arms":[{"label":"DAPTACEL Primed","type":"EXPERIMENTAL"},{"label":"Pentacel Primed","type":"EXPERIMENTAL"}],"summary":"Primary Objectives:\n\n1. To present the safety profile after a 5th dose of DAPTACEL® in children 4 to 6 years of age who have previously received 4 doses of DAPTACEL® or Pentacel™.\n2. To present the pre-Dose 5 and post-Dose 5 antibody responses to the antigens in DAPTACEL® in children 4 to 6 years of age who have previously received 4 doses of DAPTACEL® or Pentacel™.\n\nObservational Objectives:\n\n1. To compare under equivalence criteria the pre-Dose 5 and post-Dose 5 antibody responses to the antigens in DAPTACEL® in children 4 to 6 years of age who have previously received 4 doses of DAPTACEL® or Pentacel™.\n2. To present the pre-vaccination anti-poliovirus GMTs and seroprotection rates.\n3. To present the post-vaccination anti-poliovirus GMTs and seroprotection rates among subjects receiving a 4th dose of IPV concurrently with the 5th dose of DAPTACEL and a 2nd dose of MMR.","primaryOutcome":{"measure":"Percentage of Participants Reporting Solicited Local or Systemic Reactions Post-Dose 5 of DAPTACEL® Vaccination","timeFrame":"0 to 7 days Post-Dose 5","effectByArm":[{"arm":"DAPTACEL®-Primed","deltaMin":75,"sd":null},{"arm":"Pentacel®-Primed","deltaMin":70,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":22,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://www.sanofipasteur.com"]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":487},"commonTop":["Injection site tenderness","Irritability","Injection site redness","Upper respiratory tract infection NOS","Lethargy"]}}